386 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Eu Ivd Class B
×
PARASITOLOGY - OTHER
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
NOROVIRUS - NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·4 countries
ENTAMOEBA HISTOLYTICA
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·Not intended for eu market
ENTAMOEBA HISTOLYTICA
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
ENTAMOEBA HISTOLYTICA
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
ENTAMOEBA HISTOLYTICA
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
CRYPTOSPORIDIUM
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
CRYPTOSPORIDIUM
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
CRYPTOSPORIDIUM
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
CRYPTOSPORIDIUM
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
C.DIFFICILE BY NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
C.DIFFICILE BY NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
Hepcidin-25 LC-MS/MS Kit
Device
EU IVDR
·
Eu Ivd Class B
·Immundiagnostik AG·On the market·1 country
GASTROINTESTINAL INFECTIONS - MULTIPLEX NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
GASTROINTESTINAL INFECTIONS - MULTIPLEX NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
C.DIFFICILE BY NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
GASTROINTESTINAL INFECTIONS - MULTIPLEX NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
NOROVIRUS - NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·4 countries
H. PYLORI DETECTION BY NA REAGENTS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries
ASTROVIRUS
Device
EU IVDR
·
Eu Ivd Class B
·R-Biopharm AG·On the market·32 countries